Intramuscular alefacept improves health-related quality of life in patients with chronic plaque psoriasis

Dermatology : International Journal for Clinical and Investigative Dermatology
A Y FinlayAlefacept Clinical Study Group

Abstract

Psoriasis profoundly affects patient quality of life (QOL). Amevive (alefacept), a novel and selective biologic agent, was clinically effective and significantly improved QOL in a phase 2 study. The present placebo-controlled, randomized phase 3 study examined the effects of a 12-week course of intramuscular alefacept on QOL in 507 patients with chronic plaque psoriasis using both dermatology-specific questionnaires [Dermatology Life Quality Index (DLQI); Dermatology Quality of Life Scales (DQOLS)] and the Short Form-36 Health Survey (SF-36), a generic, general health questionnaire. All 3 QOL measures (DLQI, DQOLS, SF-36) demonstrated that alefacept 15 mg was significantly more effective than placebo in improving QOL in patients with chronic plaque psoriasis. In addition, the improvements in QOL for patients in the alefacept 15 mg group were of similar magnitude for all 3 QOL measures. The findings of this study are an important addition to the QOL literature for psoriasis treatments.

Citations

Jan 26, 2005·Journal of Cutaneous Medicine and Surgery·Gerald G Krueger
May 4, 2005·Journal of Cutaneous Medicine and Surgery·Andrew Y Finlay, Jean-Paul Ortonne
May 23, 2013·American Journal of Clinical Dermatology·Christine S AhnSteven R Feldman
Mar 12, 2005·Journal of the American Academy of Dermatology·Tamar NijstenRobert S Stern
Mar 24, 2005·Dermatology : International Journal for Clinical and Investigative Dermatology·Jochen Schmitt, Gottfried Wozel
Oct 6, 2005·Dermatology : International Journal for Clinical and Investigative Dermatology·P van de KerkhofG G Krueger
Nov 23, 2007·Dermatology : International Journal for Clinical and Investigative Dermatology·Laurence Le CleachOlivier Chosidow
Jan 12, 2008·Dermatology : International Journal for Clinical and Investigative Dermatology·Dennis A RevickiMartin Kaul
Jul 27, 2012·BMC Dermatology·Georgia AvgerinouLoukas Xaplanteris
Jan 1, 2009·Clinical, Cosmetic and Investigational Dermatology·Jennifer D BahnerNeil J Korman
Sep 13, 2012·American Journal of Clinical Dermatology·Iris H KimJenna L O'Neill
Jun 13, 2006·The Journal of Dermatological Treatment·Andrew A NelsonSteven R Feldman
Dec 1, 2007·Expert Review of Pharmacoeconomics & Outcomes Research·Noah Scheinfeld, Daniel Parish
Feb 19, 2010·Expert Opinion on Drug Metabolism & Toxicology·Jinan Chaarani, Mark Lebwohl
Apr 16, 2004·The Journal of Investigative Dermatology. Symposium Proceedings·Victoria Lewis, Andrew Y Finlay
Sep 28, 2005·The Journal of Investigative Dermatology·Yan HongboAndrew Y Finlay
Aug 30, 2008·Clinics in Dermatology·Hideaki SugiyamaNeil J Korman
Jun 19, 2008·Thoracic Surgery Clinics·Nowell SolishChristian A Murray
Jun 14, 2005·The British Journal of Dermatology·R P KatugampolaA Y Finlay
Jul 24, 2004·The British Journal of Dermatology·T KormeiliP S Yamauchi
May 21, 2009·Journal of the European Academy of Dermatology and Venereology : JEADV·T A LugerR Boggs
Mar 29, 2007·The British Journal of Dermatology·R P KatugampolaA Y Finlay
Sep 25, 2004·Journal of the American Academy of Dermatology·Alice B GottliebAlan Menter
Mar 21, 2006·Journal of the American Academy of Dermatology·Philip J Mease, M Alan Menter
Dec 31, 2005·Journal of the American Academy of Dermatology·Alan MenterMohamed Darif
Sep 29, 2004·Dermatologic Clinics·Gerald G Krueger
Nov 13, 2007·Journal of the American Academy of Dermatology·Amy PerlmutterAlan Menter
Aug 15, 2015·Journal of the American Chemical Society·Guolin ChengJin-Quan Yu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.